Outcomes | Exposure | Coefficient (95% CI)a | P-valueb | Change (%) |
---|---|---|---|---|
HRQoL | None | Reference | Â | Â |
Unilateral/Combination MSI | β: -0.02 (-0.05, 0.01) | 0.178 | -2.1 | |
Bilateral MSI | β: -0.05 (-0.09, -0.01) | 0.012 | -5.5 | |
Life space mobility | None | Reference | Â | Â |
Unilateral/Combination MSI | β: -0.24 (-0.47, -0.01) | 0.044 | -5.4 | |
Bilateral MSI | β: -0.46 (-0.78, -0.13) | 0.006 | -10.8 | |
Low IADL | None | Reference | Â | Â |
Unilateral/Combination MSI | OR: 3.25 (1.15, 9.19) | 0.026 | 53.4 | |
Bilateral MSI | OR: 3.45 (1.13, 10.59) | 0.03 | 55 | |
Falls | None | Reference | Â | Â |
Unilateral/Combination MSI | OR: 0.66 (0.32, 1.35) | 0.255 | -35.4 | |
Bilateral MSI | OR: 0.71 (0.30, 1.66) | 0.431 | -27.8 | |
Hospitalization | None | Reference | Â | Â |
Unilateral/Combination MSI | OR: 2.14 (0.31, 15.03) | 0.444 | 48.8 | |
Bilateral MSI | OR: 3.64 (0.44, 30.19) | 0.231 | 66.7 | |
Sarcopenia | None | Reference | Â | Â |
Unilateral/Combination MSI | OR: 2.27 (1.00, 5.14) | 0.051 | 26.8 | |
Bilateral MSI | OR: 2.07 (0.85, 5.04) | 0.11 | 24.5 | |
Frailty | None | Reference | Â | Â |
Unilateral/Combination MSI | OR: 1.28 (0.63, 2.59) | 0.499 | 9 | |
Bilateral MSI | OR: 1.81 (0.84, 3.91) | 0.132 | 19.2 |